We're doing some maintenance on our website between Thursday 9 May 2024 and Monday 13 May 2024. If you encounter any issues accessing our website during this time, you may need to refresh your browser to continue.
Biotechnology sector guide for the R&D Tax Incentive
Biotechnology covers the areas of life sciences, industrial processing, agriculture and environment.
Biotechnology may provide solutions in:
- food technology
- clean technology
- fuel alternatives
- molecular electronics
- improving human health through therapeutics and medical technology.
Read our guides and watch our videos to help you to self-assess the eligibility of your biotechnology activities under the R&DTI.
Biofnatics
Watch how a company making and testing a new type of biodegradable coronary stent may be eligible for the R&DTI.
Biotechnology and the R&D Tax Incentive
Biotechnology and the R&D Tax Incentive
pdf ยท 1.74 MBClinical trials determination
If you are conducting phase 0, I, II, III, pre-market pilot or pre-market pivotal stage clinical trials for an unapproved therapeutic good in Australia, you can use the Industry Research and Development (Clinical Trials) Determination 2022 - external site.
You will only need to show that your activities are covered by the determination rather than explaining how they meet all of the core R&D activity requirements.
Customer story - Alcolizer Technology
Listen to Shannon Bell, Chief Financial Officer of Alcolizer Technology, discuss how the R&D Tax Incentive has helped the company expand their product range and break into new markets.
Customer story - Australian Investment Council
Listen to Robyn Tolhurst, Manager of the Australian Investment Council, discuss the benefits of the Clinical Trials determination.
We use cookies to give you a better experience on our website. Learn more about how we use cookies and how you can select your preferences.